Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Gene_Williams
|
| gptkbp:clinicalTrialPhase |
ELU001 for ovarian cancer
|
| gptkbp:collaboratesWith |
gptkb:Memorial_Sloan_Kettering_Cancer_Center
|
| gptkbp:developedBy |
C-Dots nanotechnology
|
| gptkbp:focusesOn |
cancer therapeutics
|
| gptkbp:foundedYear |
2014
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Monmouth_Junction,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elucida Oncology
|
| gptkbp:industry |
oncology
|
| gptkbp:platform |
ELU001
|
| gptkbp:specializesIn |
targeted cancer therapy
|
| gptkbp:website |
https://www.elucidaoncology.com/
|
| gptkbp:bfsParent |
gptkb:David_Scheinberg
|
| gptkbp:bfsLayer |
8
|